251 related articles for article (PubMed ID: 26363638)
21. Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach.
P JJ; Manju SL; Ethiraj KR; Elias G
Eur J Pharm Sci; 2018 Aug; 121():356-381. PubMed ID: 29883727
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, in vivo anti-inflammatory, COX-1/COX-2 and 5-LOX inhibitory activities of new 2,3,4-trisubstituted thiophene derivatives.
Qandeel NA; El-Damasy AK; Sharawy MH; Bayomi SM; El-Gohary NS
Bioorg Chem; 2020 Sep; 102():103890. PubMed ID: 32801081
[TBL] [Abstract][Full Text] [Related]
23. Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities.
Ghatak S; Vyas A; Misra S; O'Brien P; Zambre A; Fresco VM; Markwald RR; Swamy KV; Afrasiabi Z; Choudhury A; Khetmalas M; Padhye S
Bioorg Med Chem Lett; 2014 Jan; 24(1):317-24. PubMed ID: 24295787
[TBL] [Abstract][Full Text] [Related]
24. Anti-inflammatory Activity of Natural Geranylated Flavonoids: Cyclooxygenase and Lipoxygenase Inhibitory Properties and Proteomic Analysis.
Hanáková Z; Hošek J; Kutil Z; Temml V; Landa P; Vaněk T; Schuster D; Dall'Acqua S; Cvačka J; Polanský O; Šmejkal K
J Nat Prod; 2017 Apr; 80(4):999-1006. PubMed ID: 28322565
[TBL] [Abstract][Full Text] [Related]
25. Indole based peptidomimetics as anti-inflammatory and anti-hyperalgesic agents: Dual inhibition of 5-LOX and COX-2 enzymes.
Singh P; Prasher P; Dhillon P; Bhatti R
Eur J Med Chem; 2015 Jun; 97():104-23. PubMed ID: 25956953
[TBL] [Abstract][Full Text] [Related]
26. Development of Novel Pyrrole Derivatives and Their Cinnamic Hybrids as Dual COX-2/LOX Inhibitors.
Noti V; Pontiki E; Hadjipavlou-Litina D
Molecules; 2023 Dec; 28(24):. PubMed ID: 38138448
[TBL] [Abstract][Full Text] [Related]
27. Tailoring the substitution pattern of Pyrrolidine-2,5-dione for discovery of new structural template for dual COX/LOX inhibition.
Sadiq A; Mahnashi MH; Alyami BA; Alqahtani YS; Alqarni AO; Rashid U
Bioorg Chem; 2021 Jul; 112():104969. PubMed ID: 34023639
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors.
Reddy MV; Billa VK; Pallela VR; Mallireddigari MR; Boominathan R; Gabriel JL; Reddy EP
Bioorg Med Chem; 2008 Apr; 16(7):3907-16. PubMed ID: 18272371
[TBL] [Abstract][Full Text] [Related]
29. Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells.
Misra S; Ghatak S; Patil N; Dandawate P; Ambike V; Adsule S; Unni D; Venkateswara Swamy K; Padhye S
Bioorg Med Chem; 2013 May; 21(9):2551-9. PubMed ID: 23517721
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological evaluation and docking studies of α,β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A₂, cyclooxygenases, lipoxygenase and proinflammatory cytokines.
Bukhari SN; Lauro G; Jantan I; Bifulco G; Amjad MW
Bioorg Med Chem; 2014 Aug; 22(15):4151-61. PubMed ID: 24938495
[TBL] [Abstract][Full Text] [Related]
31. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
[TBL] [Abstract][Full Text] [Related]
32. Specialized oxygenated heterocyclics from Villorita cyprinoides with cyclooxygenase-2 and 5-lipoxygenase inhibitory properties.
Joy M; Chakraborty K
Food Res Int; 2018 Apr; 106():164-172. PubMed ID: 29579915
[TBL] [Abstract][Full Text] [Related]
33. DuCLOX-2/5 inhibition: a promising target for cancer chemoprevention.
Gautam S; Roy S; Ansari MN; Saeedan AS; Saraf SA; Kaithwas G
Breast Cancer; 2017 Mar; 24(2):180-190. PubMed ID: 27558792
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of benzo[1.3.2]dithiazolium ylide 1,1-dioxide derivatives as potential dual cyclooxygenase-2/5-lipoxygenase inhibitors.
Tan CM; Chen GS; Chen CS; Chang PT; Chern JW
Bioorg Med Chem; 2011 Nov; 19(21):6316-28. PubMed ID: 21958737
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of key enzymes in the inflammatory pathway by hybrid molecules of terpenes and synthetic drugs: In vitro and in silico studies.
Theoduloz C; Alzate-Morales J; Jiménez-Aspee F; Isla MI; Alberto MR; Pertino MW; Schmeda-Hirschmann G
Chem Biol Drug Des; 2019 Mar; 93(3):290-299. PubMed ID: 30294891
[TBL] [Abstract][Full Text] [Related]
37. Structure-based design, synthesis, molecular docking study and biological evaluation of 1,2,4-triazine derivatives acting as COX/15-LOX inhibitors with anti-oxidant activities.
Khoshneviszadeh M; Shahraki O; Khoshneviszadeh M; Foroumadi A; Firuzi O; Edraki N; Nadri H; Moradi A; Shafiee A; Miri R
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1602-11. PubMed ID: 27028154
[TBL] [Abstract][Full Text] [Related]
38. Dual inhibition of 5-LOX and COX-2 suppresses esophageal squamous cell carcinoma.
Shi HY; Lv FJ; Zhu ST; Wang QG; Zhang ST
Cancer Lett; 2011 Oct; 309(1):19-26. PubMed ID: 21652147
[TBL] [Abstract][Full Text] [Related]
39. Ardisia crispa roots inhibit cyclooxygenase and suppress angiogenesis.
Hamsin DE; Hamid RA; Yazan LS; Taib CN; Yeong LT
BMC Complement Altern Med; 2014 Mar; 14():102. PubMed ID: 24641961
[TBL] [Abstract][Full Text] [Related]
40. Discovery of 5-Methylthiazole-Thiazolidinone Conjugates as Potential Anti-Inflammatory Agents: Molecular Target Identification and In Silico Studies.
Haroun M; Petrou A; Tratrat C; Kolokotroni A; Fesatidou M; Zagaliotis P; Gavalas A; Venugopala KN; Sreeharsha N; Nair AB; Elsewedy HS; Geronikaki A
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
